EU – funded projects

/EU – funded projects
EU – funded projects 2019-02-26T13:42:03+00:00

CANCER IMMUNOTHERAPY

Project number: POIR.01.01.01-00-0129/18

Title: „Technology platform designed for the development and study of therapeutics used in cancer immunotherapy. Development of small molecules for the immune checkpoint blockade in combination cancer immunotherapies”.

Programme:  Measure 1.1 – „R&D projects of enterprises”,  Sub‑measure 1.1.1 – “Industrial research and development carried out by enterprises” of the Smart Growth Operational Programme 2014–2020 co-financed by the European Union from the European Regional Development Fund.

Project value [PLN]: 12 461 236.71

Contribution of EU Funds [PLN]: 9 404 996.12

Keywords: cancer, cancer immunotherapy, immune checkpoint receptors, PD-1, PD-L1, inhibitors, modulators